{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T16:13:56Z","timestamp":1776096836527,"version":"3.50.1"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T00:00:00Z","timestamp":1559001600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T00:00:00Z","timestamp":1559001600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007833","name":"Hamad Medical Corporation","doi-asserted-by":"publisher","award":["Grant number: MRC-01-17-023"],"award-info":[{"award-number":["Grant number: MRC-01-17-023"]}],"id":[{"id":"10.13039\/100007833","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12872-019-1112-5","type":"journal-article","created":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T15:03:43Z","timestamp":1559055823000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Torsemide versus furosemide after acute decompensated heart failure: a retrospective observational study"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2631-0184","authenticated-orcid":false,"given":"Alaa","family":"Rahhal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed Omar","family":"Saad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kawthar","family":"Tawengi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abed Al Raouf","family":"Assi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masa","family":"Habra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dalia","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,28]]},"reference":[{"issue":"4","key":"1112_CR1","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1161\/CIR.0b013e3182009701","volume":"123","author":"VL Roger","year":"2011","unstructured":"Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation. 2011;123(4):e18\u2013e209. \n                    https:\/\/doi.org\/10.1161\/CIR.0b013e3182009701\n                    \n                  .","journal-title":"Circulation."},{"issue":"16","key":"1112_CR2","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1161\/CIR.0b013e31829e8807","volume":"128","author":"CW Yancy","year":"2013","unstructured":"Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association task force on practice guidelines. Circulation. 2013;128(16):1810\u201352. \n                    https:\/\/doi.org\/10.1161\/CIR.0b013e31829e8807\n                    \n                  .","journal-title":"Circulation."},{"issue":"27","key":"1112_CR3","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2016;37(27):2129\u20132200m. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/ehw128\n                    \n                  .","journal-title":"Eur Heart J"},{"issue":"24","key":"1112_CR4","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1016\/j.jacc.2011.10.910","volume":"59","author":"GM Felker","year":"2012","unstructured":"Felker GM, Mentz RJ. Diuretics and ultrafiltration in acute decompensated heart failure. J Am Coll Cardiol. 2012;59(24):2145\u201353. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2011.10.910\n                    \n                  .","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"1112_CR5","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.cardfail.2010.04.005","volume":"16","author":"Heart Failure Society of America","year":"2010","unstructured":"Heart Failure Society of America. Executive summary: HFSA 2010 comprehensive heart failure practice guideline. J Card Fail. 2010;16(6):475\u2013539. \n                    https:\/\/doi.org\/10.1016\/j.cardfail.2010.04.005\n                    \n                  .","journal-title":"J Card Fail"},{"issue":"6","key":"1112_CR6","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1097\/FJC.0b013e3181a717f7","volume":"53","author":"K Harada","year":"2009","unstructured":"Harada K, Izawa H, Nishizawa T, et al. Beneficial effects of Torasemide on Systolic Wall stress and sympathetic nervous activity in asymptomatic or mildly symptomatic patients with heart failure: comparison with Azosemide. J Cardiovasc Pharmacol. 2009;53(6):468\u201373. \n                    https:\/\/doi.org\/10.1097\/FJC.0b013e3181a717f7\n                    \n                  .","journal-title":"J Cardiovasc Pharmacol"},{"issue":"7","key":"1112_CR7","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S0002-9343(01)00903-2","volume":"111","author":"Michael D Murray","year":"2001","unstructured":"Murray MD, Deer MM, Ferguson JA, et al. Open-label randomized trial of torsemide compared with furosemide therapy for patients with heart failure. Am J Med 2001;111(7):513\u2013520. \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11705426\n                    \n                  . Accessed 20 May 2018.","journal-title":"The American Journal of Medicine"},{"issue":"4","key":"1112_CR8","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S1388-9842(02)00122-8","volume":"4","author":"J Cos\u00edn","year":"2002","unstructured":"Cos\u00edn J, D\u00edez J. Torasemide in chronic heart failure: results of the TORIC study. Eur J Heart Fail. 2002;4(4):507\u201313. \n                    https:\/\/doi.org\/10.1016\/S1388-9842(02)00122-8\n                    \n                  .","journal-title":"Eur J Heart Fail"},{"key":"1112_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-016-0223-5","volume":"16","author":"AHS Aljundi","year":"2016","unstructured":"Aljundi AHS, Mohammed SFK, Patel A, et al. Inotropic agents use in patients hospitalized with acute decompensated heart failure: a retrospective analysis from a 22-year registry in a middle-eastern country (1991-2013). BMC Cardiovasc Disord. 2016;16:47. \n                    https:\/\/doi.org\/10.1186\/s12872-016-0223-5\n                    \n                  .","journal-title":"BMC Cardiovasc Disord"},{"issue":"8","key":"1112_CR10","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1002\/j.1552-4604.1998.tb04810.x","volume":"38","author":"Barry E. Bleske","year":"1998","unstructured":"Bleske BE, Welage LS, Kramer WG, Nicklas JM. Pharmacokinetics of torsemide in patients with decompensated and compensated congestive heart failure. J Clin Pharmacol 1998;38(8):708\u2013714. \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9725546\n                    \n                  . Accessed 20 May 2018.","journal-title":"The Journal of Clinical Pharmacology"},{"issue":"5","key":"1112_CR11","doi-asserted-by":"publisher","first-page":"707","DOI":"10.2217\/fca.12.54","volume":"8","author":"JJ DiNicolantonio","year":"2012","unstructured":"DiNicolantonio JJ. Should torsemide be the loop diuretic of choice in systolic heart failure? Futur Cardiol. 2012;8(5):707\u201328. \n                    https:\/\/doi.org\/10.2217\/fca.12.54\n                    \n                  .","journal-title":"Futur Cardiol"},{"issue":"5","key":"1112_CR12","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1097\/FJC.0000000000000212","volume":"65","author":"RJ Mentz","year":"2015","unstructured":"Mentz RJ, Buggey J, Fiuzat M, et al. Torsemide Versus Furosemide in Heart Failure Patients. J Cardiovasc Pharmacol. 2015;65(5):438\u201343. \n                    https:\/\/doi.org\/10.1097\/FJC.0000000000000212\n                    \n                  .","journal-title":"J Cardiovasc Pharmacol"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-019-1112-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12872-019-1112-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-019-1112-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,26]],"date-time":"2020-05-26T23:09:27Z","timestamp":1590534567000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-019-1112-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,28]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1112"],"URL":"https:\/\/doi.org\/10.1186\/s12872-019-1112-5","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,28]]},"assertion":[{"value":"11 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by Hamad Medical Corporation Medical Research Centre and Institutional Review Board in Qatar on Oct 31, 2017, approval reference <i>MRC-01-17-023.<\/i> No consent was needed to participate as the study design is retrospective observational.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"127"}}